Viridian Therapeutics, Inc.\DE (VRDN) Debt Ratio (2013 - 2026)

Viridian Therapeutics, Inc.\DE's Debt Ratio history runs 12 years deep, the most recent figure standing at 0.05 for Q1 2026.

• On a quarterly basis, Debt Ratio rose 46.17% year-over-year to 0.05 in Q1 2026; TTM through Mar 2026 was 0.05, a 46.17% increase from a year earlier, with the FY2025 full-year figure at 0.04, changed N/A from the prior year.
• Debt Ratio grew to 0.05 in Q1 2026 per VRDN's latest filing, from 0.04 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.06 in Q3 2023 and bottomed at 0.01 in Q3 2022.
• The 5-year median for Debt Ratio is 0.03 (2024), against an average of 0.03.
• Across the five-year window, Debt Ratio soared 481.03% in 2023 and plunged 56.3% in 2024, its largest moves.
• Year by year, Debt Ratio stood at 0.01 in 2022, then surged by 285.91% to 0.04 in 2023, then plunged by 35.47% to 0.03 in 2024, then jumped by 43.2% to 0.04 in 2025, then advanced by 20.14% to 0.05 in 2026.
• Per Business Quant, the three latest VRDN Debt Ratio figures stand at 0.05 (Q1 2026), 0.04 (Q4 2025), and 0.04 (Q3 2025).